|Product Overview :
||Recombinant Human MST1 (Accession # AAA59872) Gln19-Arg483 ( alpha -chain) & Val484-Gly711 ( beta -chain) was produced in Chinese Hamster Ovary cell line, CHO-derived.
|Predicted N Terminal :
||No results obtained: Gln19 predicted ( alpha -chain) & Val484 ( beta -chain)
||Lyophilized from a 0.2 µm filtered solution in PBS.
||Measured by its ability to activate MSP R/Ron in MDA-MB-453 or T47D human breast cancer cells.80 ng/mL of the rhMSP significantly induces phosphorylation of MSP R/Ron measured by DuoSet® IC human phospho-MSP R/Ron kit.
|Molecular Mass :
||Recombinant Human MST1 has a calculated MW of 53 kDa ( alpha -chain), 25 kDa ( beta -chain). In SDS-PAGE migrates as 85 kDa, non-reducing conditions.
||>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).